Related Experiment Videos
Agents affecting osteolysis in patients with breast cancer
Cancer Chemotherapy and Pharmacology
|January 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013
Cancer-testis antigen expression in triple-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2010
Sweat-gland tumours: a clinical review of cases in one centre over 20 years.
Clinical oncology (Royal College of Radiologists (Great Britain))·2006
Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2005
Nocardia asteroides: an unusual cause of breast abscess.
Breast (Edinburgh, Scotland)·2004
Circulatory compromise as a potential mechanism of fatal hepatic failure during long-term selpercatinib therapy: pharmacokinetic and clinical insights.
Cancer chemotherapy and pharmacology·2026
CDCP1-targeted antibody-drug conjugates and immunocytokines for cancer therapy.
Cancer chemotherapy and pharmacology·2026
Pharmacokinetic and pharmacodynamic sub-study of trans-arterial vs. intravenous gemcitabine in the TIGeR-PaC phase 3 clinical trial.
Cancer chemotherapy and pharmacology·2026
A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer.
Cancer chemotherapy and pharmacology·2026
Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial.
Cancer chemotherapy and pharmacology·2026
Physiologically based pharmacokinetic modeling to predict human pharmacokinetics of a novel mithramycin analog for Ewing sarcoma.
Cancer chemotherapy and pharmacology·2026